The 2025 annual conference of the European Respiratory Society is set for September 27 through October 1 in Amsterdam, Netherlands. The 2025 ERS Congress is a global event that brings together respiratory professionals from around the world to discuss the latest research and share insight regarding respiratory health. The event is framed by the 2025 ERS Congress theme: Respiratory Health Around the Globe.


With five days packed with educational programs and presentation sessions, we took some time to outline the sessions related to sleep and breathing disorders. For a complete look at the full 2025 ERS Congress schedule, consult the event’s official website. These dates and times are accurate as of September 2, 2025.

Saturday, September 27

Advanced Skills in Non-invasive Ventilatory Support

  • 9:30 AM – 1:00 PM
  • Description: Session will discuss the best practices in non-invasive respiratory support therapies for patients with acute and chronic respiratory failure; to review new developments in non-invasive respiratory support therapies (from high-flow nasal oxygen therapy to non-invasive ventilation).

Update on the Treatment Concepts for Obstructive Sleep Apnea

  • 2:00 PM – 5:30 PM
  • Description: Session will discuss the available treatment options for obstructive sleep apnoea (OSA); to explain the indications, advantages and drawbacks of these different treatment concepts; to discuss the appropriate selection of different treatment modalities; to explain successful therapy and important outcomes of OSA treatment from the patient's and physician's perspectives.
Sunday, September 28

Environmental Sustainability in the Management of Airway Diseases: Novel Alpha-1 Antitrypsin Data and Innovations in Drug Delivery

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Unlocking New Pathways: Emerging Therapeutic Targets in Asthma and COPD

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Clinical Aspects in Obstructive Respiratory Disorders

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Occupational Impact on COPD, Lung Function and Obstructive Sleep Apnea Syndrome

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Pneumonia and Complicated Pneumonia: What’s New?

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Advances in Exercise Testing for Respiratory Disease

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Different Clinical Aspects of Sleep and Obstructive Sleep Apnea According to Gender, Anthropometrics and Symptoms

  • 8:00 AM – 9:30 AM
  • Description: Poster session. 

Diagnostic Techniques in the Assessment of Sleep-disordered Breathing

  • 9:00 AM – 12:30 PM
  • Description: This session will discuss various types of sleep studies including their advantages and disadvantages for the diagnosis of sleep-related breathing disorders; to systematically demonstrate the interpretation of poly(somno)graphs in adults and children using examples; to interpret poly(somno)graphy with or without capnometry under therapy (e.g., continuous positive airway pressure, adaptive support ventilation and non-invasive ventilation) of a sleep-related breathing disorder.

Sleep and Sleep-disordered Breathing in Patients with Respiratory and Neuromuscular Disorders

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Sleep, Sleep-disordered Breathing and Chronic Respiratory Insufficiency in Children I

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Understanding Disease Variability and Its Impact on the Management of Obstructive Sleep Apnea

  • 1:45 PM – 3:15 PM
  • Description: This session will systematically analyze and critically discuss these different aspects of variability in OSA in relation to datasets, OSA markers, outcomes and residual OSA on treatment and its impact on outcomes, and to discuss the importance of considering variability for treatment concepts.

Paediatric Respiratory Diseases

  • 1:45 PM – 3:15 PM
  • Description: This session will discuss important topics in paediatric respiratory medicin, such as post-infective bronchiolitis obliterans management, prematurity-associated respiratory disease , advanced interventional bronchoscopy in the management of children with complex airway diseases, as well as severe and difficult-to-treat asthma biologics and treatment.

Diagnostic Techniques in the Assessment of Sleep-disordered Breathing

  • 2:00 PM – 5:30 PM
  • Description: This session will discuss various types of sleep studies including their advantages and disadvantages for the diagnosis of sleep-related breathing disorders; to systematically demonstrate the interpretation of poly(somno)graphs in adults and children using examples; to interpret poly(somno)graphy with or without capnometry under therapy (e.g., continuous positive airway pressure, adaptive support ventilation and non-invasive ventilation) of a sleep-related breathing disorder.

Sleep and Breathing Disorders

  • 3:30 PM – 5:00 PM
  • Description: This session will present a new European Respiratory Society (ERS) statement on the treatment of central sleep apnoea (CSA) with adaptive servo-ventilation; to discuss the new treatment options for CSA in 2025.; to revise previous recommendations for treatment of celiac sleep apnoea syndromes. to update participants on the optimal treatment of patients with CSA.
Monday, September 29

Sleep, Sleep-disordered Breathing and Chronic Respiratory Insufficiency in Children II

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Novel Diagnostic Tools, Measurements and Techniques for the Prediction and Evaluation of Obstructive Sleep Apnea

  • 8:00 AM – 9:30 AM
  • Description: Poster session.

Transitioning from Basic Science to Translational Research in Sleep-disordered Breathing

  • 9:30 AM – 10:45 AM
  • Description: Oral presentation.

Exploring Fundamental Pathophysiological Aspects of Sleep-disordered Breathing

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Treatment of Sleep Apnea Beyond Positive Airway Pressure

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Emerging Insights in Diagnosis and Treatment of Sleep-disordered Breathing

  • 2:15 PM – 3:30 PM
  • Description: Oral presentation.

New Insights in Paediatric Sleep and Breathing

  • 2:15 PM – 3:30 PM
  • Description: Oral presentation.
Tuesday, September 30

Association of Sleep-disordered Breathing and Different Comorbidities

  • 8:00 AM – 9:00 AM
  • Description: Poster session.

Lungs on Fire: Respiratory Critical Care / Sleep and Breathing Disorders

  • 10:15 AM – 11:45 AM
  • Description: This session will present real-life clinical cases as part of an interactive session. Cases vary in difficulty and may require differential diagnosis. This session is led by two discussants who will present cases submitted by respiratory health professionals to a panel of experts and will drive the discussion in a step-by-step approach, encouraging dialogue and reflection among the panel, who have no prior knowledge of these cases. As the cases are discussed, the discussants will invite the audience to participate in determining which diagnostic and therapeutic options would be best for these patients.

Exploring Novel Dimensions in the Management of Sleep-Disordered Breathing

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Positive Airway Pressure Therapy for Sleep Apnea Treatment: Different Interfaces, Assessment of Outcomes and Evaluation of Compliance

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Variability in Sleep Apnea and the Association of Different Hypoxia Metrics with Sleep Apnea Diagnosis and Outcomes

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

Epidemiology of Breathlessness, Cough, Sleep Apnea, Allergy and Cormorbidities

  • 12:30 PM – 2:00 PM
  • Description: Poster session.

New Markers in Obstructive Sleep Apnea: Do They Reflect the Burden of Disease in Children and Adults?

  • 1:45 PM – 3:15 PM
  • Description: This session will demonstrate the relationship between polysomnographic measures and cardiovascular or neurocognitive outcomes in adults and children with obstructive sleep apnoea (OSA) and to address therapeutic effects on these consequences (two talks about adults, two talks about children, one about diagnostic markers and another about therapeutic effects); to identify predictors of favourable responses to continuous positive airway pressure (CPAP) in relation to cardiovascular morbidity; to compare the efficacy of CPAP for primary prevention versus secondary prevention of cardiovascular disease associated with OSA; to explain why caregiver-reported symptoms and OSA-related morbidity should likely take precedence over the apnoea-hypopnoea index (AHI) when making treatment recommendations for children with snoring; to describe the clinical challenges of using the AHI as a measure for defining residual OSA after adenotonsillectomy in children with snoring.

Sex Differences in Sleep-disordered Breathing: How Do They Influence Diagnostics and Treatment Recommendations?

  • 3:30 PM – 5:00 PM
  • Description: This session will highlight the epidemiological and pathophysiological differences between the sexes in sleep-disordered breathing and chronic respiratory failure and to critically discuss how these affect symptoms and treatment outcomes.; to identify the gaps in knowledge on sex differences in obstructive sleep apnoea, central sleep apnoea syndromes and obesity-related respiratory failure, to determine future research priorities in these areas.

Sign up for alerts and stay informed on more upcoming conference previews and conference recaps

Copyright © 2025 Guideline Central, all rights reserved.